Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Casirivimab
Cohort study
Emergency use authorization Experimental Antiviral Jan/23/2023
Imdevimab
Cohort study
Emergency use authorization Experimental Antiviral Jan/23/2023
Remdesivir
Cohort study
Approved by FDA Experimental Antiviral Jan/18/2023
Mesenchymal stem cells
Cohort study
Potential treatment - clinical evidence Experimental Other treatment Oct/17/2022
Sotrovimab
Cohort study
Emergency use authorization Experimental Antiviral Jul/14/2022
Bamlanivimab
Cohort study
Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022
Etesevimab
Cohort study
Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022
BNT162b2
Cohort study
Approved by FDA Experimental Vaccine Jun/22/2022
mRNA-1273
Cohort study
Emergency use authorization Experimental Vaccine Jun/22/2022
REGEN-COV
Cohort study
Emergency use authorization Experimental Antiviral Jun/03/2022
Convalescent plasma
Cohort study
Emergency use authorization Experimental Antiviral May/16/2022
Anakinra 
Cohort study
Recommended by guidelines Used to treat other disease Other treatment Apr/11/2022
Ivermectin
Cohort study
Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2022
Baricitinib
Cohort study
Emergency use authorization Used to treat other disease Other treatment Feb/03/2022
Colchicine
Cohort study
Potential treatment - clinical evidence Used to treat other disease Other treatment Feb/02/2022
Dexamethasone
Cohort study
Emergency use authorization Used to treat other disease Other treatment Jan/21/2022
ChAdOx1 nCoV-19
Cohort study
Emergency use authorization Experimental Vaccine Jan/04/2022
BBIBP-CorV
Cohort study
Potential treatment - clinical evidence Experimental Vaccine Dec/23/2021
Tocilizumab
Cohort study
Recommended by China's NHC Guidelines Used to treat other disease Other treatment Dec/21/2021
Methylprednisolone
Cohort study
Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/21/2021